Fig. 2.
Effects of ECP on antigen presentation.
DC antigen presenting activity is represented in autologous and allogeneic MLR using different T/DC ratios. (A) Baseline. (B) After 6 months of ECP treatment. (C) After last cycle of ECP treatment.
Effects of ECP on antigen presentation.
DC antigen presenting activity is represented in autologous and allogeneic MLR using different T/DC ratios. (A) Baseline. (B) After 6 months of ECP treatment. (C) After last cycle of ECP treatment.
